# INCB018424 in Patients With Advanced Hematologic Malignancies

> **NCT00674479** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 51 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphocytic Leukemia
- Myelodysplastic Syndrome
- Chronic Myelogenous Leukemia

## Interventions

- **DRUG:** INCB018424

## Key facts

- **NCT ID:** NCT00674479
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05-12
- **Primary completion:** 2017-03-23
- **Final completion:** 2017-03-23
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2025-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00674479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00674479, "INCB018424 in Patients With Advanced Hematologic Malignancies". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00674479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*